Resources

Recent advancements in the screening, diagnosis, and treatment of kidney disease have created an unprecedented opportunity for employers and other plan sponsors to intervene earlier to delay or prevent progression […]

Recent advancements in the screening, diagnosis, and treatment of kidney disease have created an unprecedented opportunity for employers and other plan sponsors to intervene earlier to delay or prevent progression […]

A new analysis of commercial prices for high-volume procedures finds that hospital prices were 7% higher on average at large 340B hospitals compared with non-340B hospitals of similar size, equivalent […]

Recent advancements in the screening, diagnosis, and treatment of chronic kidney disease (CKD) have created an unprecedented opportunity for employers to be a part of vital efforts to intervene earlier to delay or prevent progression to kidney failure (also known as end-stage renal disease or ESRD).

Another major employer is facing an ERISA fiduciary lawsuit—this time, it’s JPMorgan, marking the 4th employer accused of mismanaging health benefit plans. With similar cases already targeting J&J, Wells Fargo, […]

Employers face ongoing challenges in aligning with their pharmacy benefit management (PBM) service providers. This session offers a deep dive into the resources available to help employers navigate these complexities […]